HERON THERAPEUTICS INC (HRTX) — insider trading
Health Care · NASDAQ
HERON THERAPEUTICS INC (HRTX) has 60 reported SEC Form 4 insider transactions in our data (latest 2026-08-06).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-06 | Hensley Mark Earl | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 31,250 | — | $0 | Form 4 |
| 2026-08-06 | Hensley Mark Earl | Officer (Chief Operating Officer) | Shares withheld for taxes / exercise cost | 8,888 | $0.5 | $4.4K | Form 4 |
| 2026-08-06 | Hensley Mark Earl | Officer (Chief Operating Officer) | Option exercise / conversion | 31,250 | — | — | Form 4 |
| 2026-07-31 | Collard Craig A | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 34,789 | — | $0 | Form 4 |
| 2026-07-31 | Collard Craig A | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 34,789 | — | — | Form 4 |
| 2026-07-31 | Duarte Ira | Officer (EVP, Chief Financial Officer) | Option exercise / conversion (derivative) | 11,694 | — | $0 | Form 4 |
| 2026-07-31 | Duarte Ira | Officer (EVP, Chief Financial Officer) | Shares withheld for taxes / exercise cost | 3,326 | $0.5 | $1.7K | Form 4 |
| 2026-07-31 | Duarte Ira | Officer (EVP, Chief Financial Officer) | Option exercise / conversion | 11,694 | — | — | Form 4 |
| 2026-07-31 | Forbes William P | Officer (EVP, Chief Development Officer) | Option exercise / conversion (derivative) | 11,694 | — | $0 | Form 4 |
| 2026-07-31 | Forbes William P | Officer (EVP, Chief Development Officer) | Shares withheld for taxes / exercise cost | 3,326 | $0.5 | $1.7K | Form 4 |
| 2026-07-31 | Forbes William P | Officer (EVP, Chief Development Officer) | Option exercise / conversion | 11,694 | — | — | Form 4 |
| 2026-07-31 | Hensley Mark Earl | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 11,769 | — | $0 | Form 4 |
| 2026-07-31 | Hensley Mark Earl | Officer (Chief Operating Officer) | Option exercise / conversion | 11,769 | — | — | Form 4 |
| 2026-07-30 | Collard Craig A | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 50,021 | — | $0 | Form 4 |
| 2026-07-30 | Collard Craig A | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 50,021 | — | — | Form 4 |
| 2026-07-30 | Duarte Ira | Officer (EVP, Chief Financial Officer) | Option exercise / conversion (derivative) | 13,535 | — | $0 | Form 4 |
| 2026-07-30 | Duarte Ira | Officer (EVP, Chief Financial Officer) | Shares withheld for taxes / exercise cost | 3,850 | $0.5 | $1.9K | Form 4 |
| 2026-07-30 | Duarte Ira | Officer (EVP, Chief Financial Officer) | Option exercise / conversion | 13,535 | — | — | Form 4 |
| 2026-07-30 | Forbes William P | Officer (EVP, Chief Development Officer) | Option exercise / conversion (derivative) | 11,769 | — | $0 | Form 4 |
| 2026-07-30 | Forbes William P | Officer (EVP, Chief Development Officer) | Shares withheld for taxes / exercise cost | 3,348 | $0.5 | $1.7K | Form 4 |
| 2026-07-30 | Forbes William P | Officer (EVP, Chief Development Officer) | Option exercise / conversion | 11,769 | — | — | Form 4 |
| 2026-07-19 | Duarte Ira | Officer (EVP, Chief Financial Officer) | Option exercise / conversion (derivative) | 3,874 | — | $0 | Form 4 |
| 2026-07-19 | Duarte Ira | Officer (EVP, Chief Financial Officer) | Shares withheld for taxes / exercise cost | 1,101 | $0.47 | $517 | Form 4 |
| 2026-07-19 | Duarte Ira | Officer (EVP, Chief Financial Officer) | Option exercise / conversion | 3,874 | — | — | Form 4 |
| 2026-07-19 | Forbes William P | Officer (EVP, Chief Development Officer) | Option exercise / conversion (derivative) | 3,874 | — | $0 | Form 4 |
| 2026-07-19 | Forbes William P | Officer (EVP, Chief Development Officer) | Shares withheld for taxes / exercise cost | 1,101 | $0.47 | $517 | Form 4 |
| 2026-07-19 | Forbes William P | Officer (EVP, Chief Development Officer) | Option exercise / conversion | 3,874 | — | — | Form 4 |
| 2026-07-19 | Collard Craig A | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 13,797 | — | $0 | Form 4 |
| 2026-07-19 | Collard Craig A | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 13,797 | — | — | Form 4 |
| 2026-06-16 | Duarte Ira | Officer (EVP, Chief Financial Officer) | Option exercise / conversion (derivative) | 12,500 | — | $0 | Form 4 |
| 2026-06-16 | Duarte Ira | Officer (EVP, Chief Financial Officer) | Shares withheld for taxes / exercise cost | 3,555 | $0.38 | $1.4K | Form 4 |
| 2026-06-16 | Duarte Ira | Officer (EVP, Chief Financial Officer) | Option exercise / conversion | 12,500 | — | — | Form 4 |
| 2026-06-06 | Forbes William P | Officer (EVP, Chief Development Officer) | Option exercise / conversion (derivative) | 12,500 | — | $0 | Form 4 |
| 2026-06-06 | Forbes William P | Officer (EVP, Chief Development Officer) | Option exercise / conversion | 12,500 | — | — | Form 4 |
| 2026-05-06 | Hensley Mark Earl | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 125,000 | — | $0 | Form 4 |
| 2026-05-06 | Hensley Mark Earl | Officer (Chief Operating Officer) | Option exercise / conversion | 125,000 | — | — | Form 4 |
| 2026-04-30 | Collard Craig A | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 50,021 | — | $0 | Form 4 |
| 2026-04-30 | Collard Craig A | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 34,789 | — | $0 | Form 4 |
| 2026-04-30 | Collard Craig A | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 50,021 | — | — | Form 4 |
| 2026-04-30 | Collard Craig A | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 34,789 | — | — | Form 4 |
| 2026-04-30 | Duarte Ira | Officer (EVP, Chief Financial Officer) | Option exercise / conversion (derivative) | 13,535 | — | $0 | Form 4 |
| 2026-04-30 | Duarte Ira | Officer (EVP, Chief Financial Officer) | Option exercise / conversion (derivative) | 11,694 | — | $0 | Form 4 |
| 2026-04-30 | Duarte Ira | Officer (EVP, Chief Financial Officer) | Option exercise / conversion | 13,535 | — | — | Form 4 |
| 2026-04-30 | Duarte Ira | Officer (EVP, Chief Financial Officer) | Option exercise / conversion | 11,694 | — | — | Form 4 |
| 2026-04-30 | Forbes William P | Officer (EVP, Chief Development Officer) | Option exercise / conversion (derivative) | 11,770 | — | $0 | Form 4 |
| 2026-04-30 | Forbes William P | Officer (EVP, Chief Development Officer) | Option exercise / conversion (derivative) | 11,694 | — | $0 | Form 4 |
| 2026-04-30 | Forbes William P | Officer (EVP, Chief Development Officer) | Option exercise / conversion | 11,770 | — | — | Form 4 |
| 2026-04-30 | Forbes William P | Officer (EVP, Chief Development Officer) | Option exercise / conversion | 11,694 | — | — | Form 4 |
| 2026-04-30 | Hensley Mark Earl | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 11,770 | — | $0 | Form 4 |
| 2026-04-30 | Hensley Mark Earl | Officer (Chief Operating Officer) | Option exercise / conversion | 11,770 | — | — | Form 4 |
| 2026-04-19 | Duarte Ira | Officer (EVP, Chief Financial Officer) | Option exercise / conversion (derivative) | 3,874 | — | $0 | Form 4 |
| 2026-04-19 | Duarte Ira | Officer (EVP, Chief Financial Officer) | Option exercise / conversion | 3,874 | — | — | Form 4 |
| 2026-04-19 | Collard Craig A | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 13,797 | — | $0 | Form 4 |
| 2026-04-19 | Collard Craig A | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 13,797 | — | — | Form 4 |
| 2026-04-19 | Forbes William P | Officer (EVP, Chief Development Officer) | Option exercise / conversion (derivative) | 3,874 | — | $0 | Form 4 |
| 2026-04-19 | Forbes William P | Officer (EVP, Chief Development Officer) | Option exercise / conversion | 3,874 | — | — | Form 4 |
| 2026-04-03 | Collard Craig A | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 62,500 | — | $0 | Form 4 |
| 2026-04-03 | Collard Craig A | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 62,500 | — | — | Form 4 |
| 2026-01-30 | Collard Craig A | Director, Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 800,336 | — | $0 | Form 4 |
| 2026-01-30 | Collard Craig A | Director, Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 800,337 | — | $0 | Form 4 |
Ask the chat about HRTX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: HERON THERAPEUTICS INC (HRTX).
Last updated 2026-08-06 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.